Olema Pharmaceuticals, Inc. OLMA Investment Income Nonoperating

Investment Income Nonoperating at other companies

Williams CompaniesWMB

$0+100%

Lincoln Educational Services CorporationLINC

$30K-73.7%

ARS Pharmaceuticals, Inc.SPRY

$1.97M-39.2%

Apollo Global ManagementAPO

$85M-77.0%

JBT Marel CorporationJBTM

$2M0.0%

Olaplex Holdings, Inc.OLPX

$2.7M-54.6%

Other financials

Income statement

See full

Operating income-$58.0M-66.3%

Net income-$53.1M-74.7%

EPS (diluted)-$0.52-44.4%

Balance sheet

See full

Cash & equivalents$52.5M+3.8%

Total debt$956.0K-16.7%

Total equity$480.5M+25.3%

Total assets$530.6M+29.5%

Cash flow

See full

Operating cash flow-$46.0M-4.6%

CapEx-—

Free cash flow-$34.5M-27.8%

Valuation

See full

Market cap$998.38M+253%

Enterprise value$946.79M+306%

Returns & leverage

See full

Return on equity-42.9%+1.3pp

Debt / equity0×0.0×

Current ratio10.9×-4.3×

Where this comes from

Reported directly by Olema Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeNonoperating.

The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Olema Pharmaceuticals, Inc.'s investment income nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Olema Pharmaceuticals, Inc.'s investment income nonoperating?: Olema Pharmaceuticals, Inc. (OLMA) reported investment income nonoperating of $1.27M in Q1 2026.
How has Olema Pharmaceuticals, Inc.'s investment income nonoperating changed year-over-year?: Olema Pharmaceuticals, Inc.'s investment income nonoperating decreased by 39.4% year-over-year, from $2.1M to $1.27M.